Library Contained In Or Displayed By A Micro-organism (e.g., Bacteria, Animal Cell, Etc.) Or Library Contained In Or Displayed By A Vector (e.g., Plasmid, Etc.) Or Library Containing Only Micro-organisms Or Vectors Patents (Class 506/14)
-
Publication number: 20100285136Abstract: The present invention concerns a system, comprising bacteriophages and particles comprising active agents, in which a first additional peptide is fused to proteins of the bacteriophage, the first additional peptide adheres to the surface of the particle and furthermore a second additional peptide is fused to proteins of the bacteriophage. The second additional peptide can adhere on substrate surfaces. The present invention furthermore concerns the use of the system for delayed release of active agents and also a method for production of the system. The present invention furthermore concerns a method for the selection of phage species from a combinatorial phage population.Type: ApplicationFiled: August 1, 2008Publication date: November 11, 2010Applicant: Bayer Technology Services GMBHInventors: Stefanie Eiden, Axel Eble, Martin Weiss, Daniel Gordon Duff, Olaf Bork, Holger Egger, Bastian Budde, Sascha Plug
-
Publication number: 20100285979Abstract: The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.Type: ApplicationFiled: August 27, 2008Publication date: November 11, 2010Inventors: Martha Allen Zeiger, Nijaguna B. Prasad, Steven K. Libutti, Christopher B. Umbricht
-
Publication number: 20100285993Abstract: The present invention provides genomic DNA libraries that are systematically arranged on plasmids, methods of making and using the libraries, and plasmids that make up the libraries.Type: ApplicationFiled: February 7, 2007Publication date: November 11, 2010Inventor: Gregory Prelich
-
Patent number: 7829504Abstract: Peptides have been generated that have binding affinity to carbon nanostructures and particularly carbon nanotubes. Peptides of or the invention are generally about twelve amino acids in length. Methods for generating carbon nanotube binding peptides are also disclosed.Type: GrantFiled: February 13, 2006Date of Patent: November 9, 2010Assignee: E. I. du Pont de Nemours and CompanyInventors: Anand Jagota, Steven Raymond Lustig, Siqun Wang, Hong Wang
-
Publication number: 20100279894Abstract: The present invention relates to a composition comprising bacteriophages and coating material for surfaces, characterized in that a first additional peptide is fused on proteins of the bacteriophage and furthermore a second additional peptide is fused on proteins of the bacteriophage. In addition, the present invention relates to a surface that has been coated with the composition and the use of the composition for coating surfaces.Type: ApplicationFiled: November 20, 2008Publication date: November 4, 2010Applicants: Bayer Technology Services GMBH, Bayer Material Science AGInventors: Stefanie Eiden, Axel Eble, Bastian Budde, Sascha Plug, Peter Krüger
-
Publication number: 20100279893Abstract: A population of iPS cells derived from somatic cells from a spinal muscular atrophy patient is disclosed. In one embodiment of the invention, the cells have been cultured to produce neural cells. In another embodiment, the invention is a method of testing compounds for their ability to modify cellular SMN levels comprising the steps of obtaining a population of iPS cells derived from a spinal muscular atrophy patient or cells derived from the iPS cells, and examining the effect of a test compound on SMN levels.Type: ApplicationFiled: December 18, 2009Publication date: November 4, 2010Inventors: Clive Svendsen, Allison Ebert
-
Publication number: 20100273669Abstract: A method for selecting a peptide or polypeptide which binds to a target is provided. The method is based on protein splicing and phage display.Type: ApplicationFiled: January 18, 2007Publication date: October 28, 2010Applicant: MILLEGENInventor: Philippe Mondon
-
Publication number: 20100267057Abstract: Aspects of the invention provide compositions and methods for displaying engineered polypeptides on a cell surface. According to aspects of the invention, immobilized polypeptides can be screened to identify one or more variants having one or more functional or structural properties of interest. Aspects of the invention provide composition and methods for producing engineered protein or protein variants having a functional or a structural property of interest.Type: ApplicationFiled: August 24, 2009Publication date: October 21, 2010Inventors: James A. Rakestraw, Stan I. Letovsky, Shaun Lippow
-
Publication number: 20100260731Abstract: The invention relates to a method for propagating or concentrating primary cells without tumorous characteristics and to the subsequent use thereof.Type: ApplicationFiled: September 3, 2008Publication date: October 14, 2010Inventors: Adrianus J.C.M. Braspenning, Stefan Holder, Heiner Kupper
-
Patent number: 7811973Abstract: The present invention provides novel technologies for producing and screening fusion proteins on the surface of filamentous phage. In particular, a single vector can be used for generating cell and phage libraries containing a given series of protein sequences fused to either one or other of two phage coat proteins. This approach simplifies and improves the efficiency of the subsequent phage display-based selection of protein-binding molecules having therapeutic or diagnostic utility, such as antibodies, peptides, or epitope-binding regions.Type: GrantFiled: July 6, 2006Date of Patent: October 12, 2010Assignee: Ribovax Biotechnologies SAInventors: Roberto Burioni, Massimo Clementi
-
Publication number: 20100248986Abstract: The instant invention provides methods and kits for screening for anti-excitotoxic compounds which increase the total amount of EAAT-I protein or the surface amount of EAAT-I protein.Type: ApplicationFiled: September 5, 2008Publication date: September 30, 2010Inventor: Bonnie L. Firestein-Miller
-
Publication number: 20100249377Abstract: The invention relates to a compositions and methods for generating and using pIX phage display libraries for producing non-antibody peptide or protein proteins or peptides using engineered hybrid phage vectors derived from pIX of M 13 phageType: ApplicationFiled: November 21, 2008Publication date: September 30, 2010Inventors: Bryan Wang, Karyn O'Neil
-
Publication number: 20100248989Abstract: Methods of producing human stem cells are disclosed for parthenogenetically activating human oocytes by manipulation of O2 tension, including manipulation of Ca2+ under high O2 tension and contacting oocytes with serine threonine kinase inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated oocytes, and culturing the cells of the isolated ICMs under high O2 tension. Moreover, methods are described for the production of stems cells from activated oocytes in the absence of non-human animal products, including the use of human feeder cells/products for culturing ICM/stem cells. Stem cells produced by the disclosed methods are also described.Type: ApplicationFiled: May 28, 2010Publication date: September 30, 2010Inventors: Elena S. Revazova, Marina V. Pryzhkova, Leonid N. Kuzmichev, Jeffrey D. Janus
-
Patent number: 7803765Abstract: The present invention provides novel methods for producing nucleic acid fragment libraries that express highly diverse peptides or protein domains and, in particular, methods for producing nucleic acid fragment libraries wherein the nucleic acid.Type: GrantFiled: February 20, 2004Date of Patent: September 28, 2010Assignee: Phylogica LimitedInventors: Paul Michael Watt, Wayne Robert Thomas, Richard Hopkins
-
Publication number: 20100234244Abstract: A microarray of polymeric biomaterials is provided. Specifically, a microarray of polymeric biomaterials that comprises a base with a cytophobic surface, and a plurality of discrete polymeric biomaterial elements bound to the cytophobic surface, is provided. Preferably said polymeric biomaterials comprise a synthetic polymer. Said polymeric biomaterials may also comprise other compounds covalently or non-covalently attached to said synthetic polymer. Methods of preparing the microarray of polymeric biomaterials of the present invention and uses of the microarray of polymeric biomaterials of the present invention are also provided.Type: ApplicationFiled: May 26, 2010Publication date: September 16, 2010Inventors: Daniel G. Anderson, Robert S. Langer, David A. Putnam
-
Publication number: 20100233195Abstract: The present invention relates to compositions and methods for displaying proteins and polypeptides on the surface of cells and cellular vesicles. Methods and compositions for drug and vaccine delivery using cell surface display systems of the present invention are also disclosed.Type: ApplicationFiled: May 21, 2008Publication date: September 16, 2010Applicant: Cornell Research Foundation, Inc.Inventors: Matthew Delisa, Jae-Young Kim, David A. Putnam, Anne M. Doody
-
Publication number: 20100234243Abstract: A method for promoting the in vitro multiplication of human melanocytes and/or the freezing thereof, notably human melanocytes obtained from individuals of phototype IV, V or VI or from hyperpigmentary lesions, entails introducing into a culture of same, a thus effective amount of at least one 1-phenyl-3-(2-thiazolyl)-2-thiourea (PTU) compound or PTU analogue or PTU mimetic selected from the group consisting of vitamin C, arbutin, hydroquinone, kojic acid or acid or ester derivative thereof, ellagic acid, aminophenol derivative, procysteine or derivative thereof, niacinamide, isothiocyanate, thiocyanate, lucinol and mixtures thereof; also provided thereby can be melanocyte libraries, co-cultures and reconstructed epidermides and/or reconstructed skin that are highly pigmented which are useful for the study of pigmentation disorders, for the screening of cosmetic or dermatological active agents, or for the treatment of skin lesions, in particular in individuals with a high phototype.Type: ApplicationFiled: February 18, 2010Publication date: September 16, 2010Applicant: L'OREALInventors: Marcelle REGNIER, Claire Tremblaye
-
Publication number: 20100227774Abstract: Compositions are provided that comprise antibody against membrane proteins such as chemokine receptors. In particular, monoclonal human antibodies against human CXCR4 are provided that are capable of inhibiting HIV infection and chemotaxis in human breast cancer cells. The antibodies can be used as prophylactics or therapeutics to prevent and treat HIV infection and cancer, for screening drugs, and for diagnosing diseases or conditions associated with interactions with chemokine receptors.Type: ApplicationFiled: February 26, 2010Publication date: September 9, 2010Applicant: ADIMAB, INC.Inventors: SHAOBING HUA, LI ZHU
-
Publication number: 20100216659Abstract: The present invention provides methods for identifying cognate binding pairs from two libraries of biomolecules (e.g., polypeptides). The methods typically involve displaying a first library of candidate biomolecules (e.g., receptors or epitopes) on a first replicable genetic package (e.g., a cell surface display platform) and displaying a second library of candidate biomolecules (e.g., ligands) on a second replicable genetic package (e.g., a phage display platform), contacting the first library with the second library, and then selecting members of the first library to which a member of the second library is bound. Also provided in the invention are compositions and kits for carrying out the methods of the invention.Type: ApplicationFiled: June 16, 2008Publication date: August 26, 2010Applicant: The Scipps Research InstituteInventors: Diana R. Bowley, Teresa Jones, Dennis R. Burton, Richard A. Lerner
-
Patent number: 7776794Abstract: The invention relates to a biosensor comprising living cells that express a chemosensor, or receptor, on their surface. When grown on a microarray comprising electrodes, the cells can be induced, by binding of a ligand to the receptor, to secrete a molecule. This secretion event is detected with millisecond temporal resolution via electrochemical oxidation of the secreted molecule on the electrode which is voltage-clamped slightly above its redox potential. The current so generated is indicative of the amount of the ligand bound to the receptor.Type: GrantFiled: September 20, 2004Date of Patent: August 17, 2010Assignee: The Research Foundation of State University of New YorkInventors: Ben G. Szaro, James Castracane, Xiaojun Feng
-
Publication number: 20100199360Abstract: The present invention relates to a novel class of gene trap vector (enhanced gene trap vectors, eGTV) for efficiently identifying silent or weakly expressed target genes in mammalian genomes, methods of their production and methods for identifying and mutating target genes by using the enhanced gene trap vectors. The gene trap vectors of the present invention can also be used for inducing the expression of silent genes and enhancing the expression of weakly expressed genes. The use of the enhanced gene trap vectors for creating transgenic organisms to identify gene function and to validate pharmaceutical compounds prior to clinical applications is a further aspect of the present invention.Type: ApplicationFiled: November 28, 2005Publication date: August 5, 2010Applicants: FRANKGEN BIOTECHNOLOGIE AG., GSF FORSCHUNGSZENTRUM FUR UMWELT UND GESUNDHEIT GMBH, MPG MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.Inventors: Harald Von Melchner, Frank Schnutgen, Wolfgang Wurst, Patricia Ruiz
-
Publication number: 20100184615Abstract: The present invention relates to a method of preparing a genetic package displaying oligomers of modular antibody domains binding to a target and to a scaffold ligand as well as to vectors and libraries of genetic packages produced thereby. The invention further relates to methods of selecting suitable linker sequences for use in such oligomer display.Type: ApplicationFiled: June 26, 2008Publication date: July 22, 2010Inventors: Gottfried Himmler, Florian Ruker, Gerda Redl, Gordana Wozniak-Knopp, Geert Mudde
-
Publication number: 20100184612Abstract: The present disclosure relates to novel triple tag sequences that may comprise a 6× histidine tag, a c-myc tag and a V5 tag. The present disclosure also provides polynucleotides, proteins, vectors and host cells that comprise the triple tag sequence of the present disclosure, including libraries of such polynucleotides, proteins, vectors and host cells. The novel triple tag sequences of the present disclosure may be used in phage display vectors and phage libraries and in methods for detection, screening, capture, purification, quantitation, and/or recovery of proteins of interest to which they are linked. Proteins of interest include antibodies such as single chain antibodies, single chain antibodies, and Fab fragments of antibodies or peptides such as non-antibody peptides.Type: ApplicationFiled: October 2, 2009Publication date: July 22, 2010Applicant: XOMA TECHNOLOGY, LTD.Inventors: Isaac Rondon, Marina Roell, Daniel Bedinger
-
Publication number: 20100184619Abstract: A method for analyzing an organelle-localized protein, which enables one to determine whether or not a test protein localizes to an organelle, comprising the steps of: (a) a step of introducing a fusion peptide (a), which comprises one half-peptide of an intein, one half-peptide of a fluorescent protein and an organelle-targeting signal peptide, into a eukaryotic cell; (b) a step of introducing a test protein bound to a fusion peptide (b), which comprises the other half-peptide of the fluorescent protein and the other half-peptide of the intein, into the eukaryotic cell; and (c) a step of detecting fluorescence signal emitted by the fluorescent protein, and a material for analysis to be used in such method are provided.Type: ApplicationFiled: January 21, 2010Publication date: July 22, 2010Inventors: Yoshio Umezawa, Takeaki Ozawa
-
Publication number: 20100179071Abstract: A method for producing a cell pattern is provided, comprising the step of forming a hydrophobic film on a substrate, patterning the hydrophobic film by a laser beam, transferring the hydrophobic film from the substrate to a medium, and culturing cells on the medium to form a cell pattern.Type: ApplicationFiled: May 19, 2009Publication date: July 15, 2010Applicant: NATIONAL TAIWAN UNIVERSITYInventors: Chin-Hsiung Hsieh, Yi-You Huang
-
Publication number: 20100173801Abstract: Methods and compositions using populations of randomized modified FRT recombination sites to identify, isolate and/or characterize modified FRT recombination sites are provided. Kits comprising the library populations of FRT sites are also provided, as are methods to make a library of modified FRT recombination sites. The recombinogenic modified FRT recombination sites can be employed in a variety of methods for targeted recombination of polynucleotides of interest.Type: ApplicationFiled: February 16, 2010Publication date: July 8, 2010Inventors: YUMIN TAO, DENNIS L. BIDNEY, WILLIAM J. GORDON-KAMM, LESZEK A. LYZNIK
-
Publication number: 20100170006Abstract: The disclosure relates to methods for modulating plant growth and organogenesis using dominant-negative receptor-like kinases.Type: ApplicationFiled: December 18, 2009Publication date: July 1, 2010Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Zhenbiao Yang, Stephen Karr
-
Patent number: 7741037Abstract: The present invention is directed generally to a method of identifying an insect pheromone. Initially, a candidate insect pheromone-binding protein is obtained and sequenced. Specific proteins may then be selected by observing the pattern of pheromone-binding protein expression in the insect stage, phase or caste; and/or in the antenna and other sensilla by, for example, in situ hybridization; and/or by comparison with sequence of known pheromone binding proteins. A composition of one or more pheromones may then be contacted with the pheromone-binding protein. Any pheromones bound to the protein may then be eluted and analyzed.Type: GrantFiled: February 16, 2006Date of Patent: June 22, 2010Assignee: Board of Regents, The University of Texas SystemInventor: Robert David Renthal
-
Publication number: 20100144546Abstract: The present invention relates to the fields of microbiology, molecular biology and protein biochemistry. More particularly, it relates to compositions and methods for analyzing and altering (e.g., enhancing or inhibiting) protein folding and solubility (e.g., within periplasm). The present invention provides an engineered assay for protein folding and solubility in the E. coli periplasm based on co-translational translocation of a chimera comprising a protein of interest fused to TEM-I ?-lactamase that is targeted for export via the signal recognition particle (SRP)-dependent pathway. Using an array of native and heterologous proteins, it is demonstrated that periplasmic folding behavior of proteins is intimately coupled to in vivo ?-lactamase activity. As a result of this coupling, the reporter is useful for (1) facile discovery of extrinsic periplasmic factors that affect protein folding and solubility; and (2) genetic selection of solubility-enhanced proteins.Type: ApplicationFiled: January 14, 2008Publication date: June 10, 2010Applicant: CORNELL UNIVERSITYInventors: Matthew P. Delisa, Thomas J. Mansell, Adam C. Fisher
-
Publication number: 20100144548Abstract: The present invention relates generally to the field of molecular biology and genomics. More specifically, the present invention concerns the cloning of nucleic acid molecules and the production of nucleic acid libraries, as well as the expression of recombinant proteins and bactofection.Type: ApplicationFiled: August 3, 2007Publication date: June 10, 2010Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATIONInventors: Waclaw Szybalski, Jadwiga Wild, Zdenka Hradecna, David Frisch, Frederick R. Blattner, Katarzyna Gromek
-
Publication number: 20100144549Abstract: Primate parthenotes, cells derived from them, and libraries of such cells are disclosed. Additionally, methods are disclosed for making primate parthenotes, the production of embryonic cells from these parthenotes, and for differentiating the partenotes into desired cell types, including multi-potent and differentiated cells. Methods are also provided for treating diseases or conditions for which the desired cell types are beneficial. Methods to identify agents of interest using these cells are also described.Type: ApplicationFiled: July 18, 2008Publication date: June 10, 2010Inventor: Shoukhart M. Mitalipov
-
Publication number: 20100137162Abstract: The present invention provides an array for rapidly identifying a host cell population capable of producing heterologous protein with improved yield and/or quality. The array comprises one or more host cell populations that have been genetically modified to increase the expression of one or more target genes involved in protein production, decrease the expression of one or more target genes involved in protein degradation, or both. One or more of the strains in the array may express the heterologous protein of interest in a periplasm compartment, or may secrete the heterologous protein extracellularly through an outer cell wall. The strain arrays are useful for screening for improved expression of any protein of interest, including therapeutic proteins, hormones, a growth factors, extracellular receptors or ligands, proteases, kinases, blood proteins, chemokines, cytokines, antibodies and the like.Type: ApplicationFiled: October 30, 2009Publication date: June 3, 2010Applicant: Pfenex Biopharmaceuticals, Inc.Inventors: Diane M. Retallack, Charles H. Squires, Thomas M. Ramseier, Russell J. Coleman, Jane C. Schneider, Charies D. Hershberger
-
Patent number: 7723270Abstract: A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof, by virtue of the sbp member or a polypeptide component thereof being expressed as a fusion with a capsid component of the rgdp. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected rgdps for expression of the selected sbp members. Antibody sbp members may be thus obtained, with the different chains thereof expressed, one fused to the capsid component and the other in free form for association with the fusion partner polypeptide. A phagemid may be used as an expression vector, with said capsid fusion helping to package the phagemid DNA.Type: GrantFiled: October 13, 1999Date of Patent: May 25, 2010Assignees: Medical Research Council, Medimmune LimitedInventors: John McCafferty, Anthony Richard Pope, Kevin Stuart Johnson, Henricus Renerus Jacobus Mattheus Hoogenboom, Andrew David Griffiths, Ronald Henry Jackson, Kasper Philipp Holliger, James David Marks, Timothy Piers Clackson, David John Chiswell, Gregory Paul Winter, Timothy Peter Bonnert
-
Publication number: 20100120632Abstract: This invention is directed to methods and compositions for sorting and/or determining microscopic organisms or cells. The methods and compositions are directed to the use of molecular probes to selectively stain the organisms or cells in combination with the use of binding partners to selectively immobilize the stained organisms or cells to a solid carrier. By combining the selectivity of both molecular probes and binding partners in an orthogonal method for staining and immobilization, these methods and compositions increase both the discriminating power of the assays and/or the certainty of the result obtained therefrom.Type: ApplicationFiled: October 1, 2009Publication date: May 13, 2010Applicant: BOSTON PROBES, INC.Inventors: James M. COULL, Henrik STENDER, Brian D. GILDEA
-
Publication number: 20100120037Abstract: The invention provides a method for isolating and culturing a previously unculturable microorganism, which comprises: (i) collecting a sample from an environmental source; (ii) counting/estimating the number of microorganisms in the sample; (iii) diluting the sample in an appropriate medium; (iv) adding a gelating agent such as to entrap one or more microorganisms within a sphere of the gelating agent; (v) coating the spheres containing the entrapped microorganism(s) with a natural or synthetic polymer to form a polymeric membrane; (vi) incubating the coated spheres in the original environment for an appropriate time; (vii) cutting the spheres and scanning for microorganisms colonies; and (viii) isolating the microorganisms, and repeating steps (iii) to (vii) until a pure clone of said previously unculturable microorganism is obtained.Type: ApplicationFiled: August 7, 2009Publication date: May 13, 2010Inventors: Ariel Kushmaro, Shimona Geresh, Shaul Geresh
-
Publication number: 20100113300Abstract: A proteinaceous particle, for example a bacteriophage, ribosome or cell, displaying on its surface a T-cell receptor (TCR). The displayed TCR is preferably a heterodimer having a non-native disulfide bond between constant domain residues. Such display particles may be used for the creation of diverse TCR libraries for the identification of high affinity TCRs. Several high affinities are disclosed.Type: ApplicationFiled: October 21, 2009Publication date: May 6, 2010Applicant: IMMUNOCORE LIMITEDInventors: Bent Karsten Jakobsen, Torben Bent Andersen, Peter Eamon Molloy, Yi Li, Jonathan Michael Boulter
-
Publication number: 20100113303Abstract: Disclosed herein are expression vectors which display a passenger polypeptide on the outer surface of a biological entity. As disclosed herein the displayed passenger polypeptide is capable of interacting or binding with a given ligand. Also disclosed are methods of making and using the expression vectors. N/C terminal fusion expression vectors and methods of making and using are also disclosed.Type: ApplicationFiled: September 21, 2009Publication date: May 6, 2010Inventors: Patrick S. Daugherty, Paul H. Bessette, Jeffrey Rice
-
Publication number: 20100113304Abstract: The present invention provides a polynucleotide vector system used during polypeptide display that can be used to facilitate transfer of pools of polynucleotides encoding antigen binding proteins of interest. The present invention also provides methods that allow seamless conversion of pools of polynucleotides encoding antigen binding proteins using a restriction enzyme digestion and ligation strategy.Type: ApplicationFiled: September 25, 2009Publication date: May 6, 2010Applicant: WYETHInventors: Simon Evan Hufton, William James Jonathan Finlay
-
Publication number: 20100113302Abstract: Methods and compositions are provided for producing libraries of soluble random polypeptides. In the methods, the fraction of hydrophilic residues in the polypeptide is controlled so as to maintain the solubility of the polypeptide constructs.Type: ApplicationFiled: February 12, 2008Publication date: May 6, 2010Applicant: PROTEONOVA, INCInventor: Richard B Williams
-
Publication number: 20100099096Abstract: The present invention is directed to retroviral vectors, and libraries generated from the vectors that can be used in assessing the stability of proteins and in correlating degradation with a specific E3 ubiquitin ligase. The libraries can also be used to identify factors that alter the degradation of proteins of therapeutic value and which have potential use clinically.Type: ApplicationFiled: February 26, 2008Publication date: April 22, 2010Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.Inventors: Stephen Elledge, Hsueh-Chi Yen
-
Publication number: 20100093562Abstract: The present invention relates to high content surface areas containing nickel and/or cobalt metallic compounds assembled on a modified Tobacco mosaic virus (TMV) template, wherein the modified TMV template is engineered to encode unique placement of cysteine residues that self-assemble onto gold patterned surfaces in a substantially aligned fashion, producing a >10 fold increase in surface area. Deposition of ionic metals onto the surface assembled virus templates produce uniform metal coatings for the fabrication of oriented high surface area materials.Type: ApplicationFiled: December 28, 2007Publication date: April 15, 2010Applicants: UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE, PURDUE RESEARCH FOUNDATIONInventors: James N. Culver, Michael Harris, Elizabeth Royston
-
Publication number: 20100093561Abstract: The present invention relates to the fields of life sciences and biological processes. Specifically, the invention relates to microarrays and live cell based screening and molecular analysis. More specifically, the present invention relates to novel methods for the screening of the effects of a test compound on cells, for molecular analysis of the cells and for producing a microarray. The present invention also relates to cell arrays and the use of arrays for molecular analysis of the cells or for the screening of agents.Type: ApplicationFiled: October 9, 2008Publication date: April 15, 2010Applicant: VALTION TEKNILLINEN TUTKIMUSKESKUSInventors: Juha Rantala, Petri Saviranta, Olli Kallioniemi
-
Publication number: 20100086485Abstract: The present invention relates to a live-attenuated bacterial cell comprising a heterologous nucleotide sequence encoding at least one influenza virus antigen in operative linkage to an expression system.Type: ApplicationFiled: January 17, 2007Publication date: April 8, 2010Inventor: Heiko Apfel
-
Publication number: 20100075868Abstract: The present invention relates to the description of an approach for developing tissue proteome library, which overexpresses all the transcripts (mRNAs) present in a given tissue. Transcripts of interest present in a tissue are normally cloned and overexpressed individually to enable purification of expressed protein and for conducting its structure-function studies. Methods for identification of novel and low abundant transcripts present in tissues are not available, particularly of specimen tissue samples, oocytes and early embryos, for which tissue availability is also a serious limitation. Expression of all the transcripts present in a tissue and comparison of the profile of total expressed protein with that of appropriate controls can be used in identification of all and particularly novel transcripts present in a tissue.Type: ApplicationFiled: August 31, 2009Publication date: March 25, 2010Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHInventor: Bulusu S. Murthy
-
Publication number: 20100070186Abstract: Described herein are methods of mapping in cultured cells a recessive genotypic or phenotypic variation to a region of a genetic sequence, methods of screening cells in. cell culture for genotypic or phenotypic variations, methods of mutagenizing cells, and methods of using genetic sequences identified by one or more methods described herein.Type: ApplicationFiled: March 15, 2007Publication date: March 18, 2010Inventor: Bryan R. Soper
-
Publication number: 20100069251Abstract: Means for producing embryonic stem (pES) cells which have a heterozygous genome that is matched to an individual donor are provided. In one embodiment, a means for the generation and isolation of parthenogenetic embryonic stem (pES) cells which have regions of heterozygosity that are fully matched to the oocyte donor at the MHC loci (e.g. (h-)p(MI)ES cells is provided. This is in contrast to the traditional methods of parthenogenesis that generate parthenogenetic embryonic stem (pES) cells having a substantially homozygous haploidentical set of chromosomes that are homozygous at the MHC loci.Type: ApplicationFiled: September 13, 2007Publication date: March 18, 2010Applicant: CHILDREN'S MEDICAL CENTER CORPORATIONInventors: Kitai Kim, George Daley
-
Publication number: 20100062950Abstract: The present invention concerns constructs and libraries comprising antibody surrogate ? light chain sequences. In particular, the invention concerns constructs comprising antibody surrogate ? light chain sequences, optionally partnered with another polypeptide, such as, for example, antibody heavy and/or light chain domain sequences, and libraries containing the same.Type: ApplicationFiled: July 10, 2009Publication date: March 11, 2010Inventors: Ramesh R. Bhatt, Lawrence Horowitz
-
Publication number: 20100062949Abstract: The present invention is directed to a fiber optic device consisting of a fiber bundle having multiple legs of silica fibers, using a plurality of microspheres construct to attach target cells, for the assay of cytotoxic compounds. Each leg of silica fibers consists of twenty-five or more silica fibers treated with biotin and streptavidin treated microspheres which chemically bind the microspheres to the silica fibers. Further, the present invention is directed to the unique microspheres. The microspheres have a core, preferably alginate, with an outer surface of chitosan. The present invention is further directed to the use of the described fiber optic device to isolate, research and develop biological medicaments and diagnostic cytotoxic compounds. The fiber optic device utilizes thousands of fibers and the unique microspheres to provide a high-throughput screening device.Type: ApplicationFiled: September 11, 2008Publication date: March 11, 2010Applicant: MABGEN, LLCInventor: DENNIS LEE
-
Publication number: 20100056386Abstract: The present invention overcomes the inadequacies inherent in the known methods for generating libraries of antibody-encoding polynucleotides by specifically designing the libraries with directed sequence and length diversity. The libraries are designed to reflect the preimmune repertoire naturally created by the human immune system, with or without DH segments derived from other species, and are based on rational design informed by examination of publicly available databases of antibody sequences.Type: ApplicationFiled: March 13, 2009Publication date: March 4, 2010Applicant: Adimab, Inc.Inventors: Maximiliano Vasquez, Michael Feldhaus, Tillman U. Gerngross, K. D. Wittrup
-
Publication number: 20100056394Abstract: The present invention discloses a bio-reaction module, the so called mini bio-reactor, for providing a stable environment for the hybridization or immuno-reaction on biochips with constant temperature and humidity. Moreover, the mini bio-reactor can be a tool for studying the bio-reaction mechanism. Any variations in bio-reaction mechanism and environmental factors may affect experiment outcomes. Hence, when bulky equipment is miniaturized into a module system, the researchers can utilize a mini bio-reactor to perform bio-experiments or reactors in series connection to perform batch experiments. The structure design of mini reactor is able to promote better reaction efficiency and to shorten reaction time for a variety of bio experiments. Hence what is developed is an automatic, handy and inexpensive device for bio researches with high sensitivity and reliability.Type: ApplicationFiled: September 4, 2008Publication date: March 4, 2010Applicant: CHUNG YUAN CHRISTIAN UNIVERSITYInventors: Yaw-Jen Chang, Cheng-Hao Chang